TELA Bio, Inc. NASDAQ:TELA

Founder-led company

TELA Bio stock price today

$1.76
-1.15
-39.52%
Financial Health
0
1
2
3
4
5
6
7
8
9

TELA Bio stock price monthly change

-42.26%
month

TELA Bio stock price quarterly change

-42.26%
quarter

TELA Bio stock price yearly change

-53.74%
year

TELA Bio key metrics

Market Cap
111.95M
Enterprise value
180.42M
P/E
-4.12
EV/Sales
3.00
EV/EBITDA
-3.00
Price/Sales
3.03
Price/Book
12.75
PEG ratio
0.71
EPS
-1.67
Revenue
63.14M
EBITDA
-43.40M
Income
-40.29M
Revenue Q/Q
39.41%
Revenue Y/Y
40.02%
Profit margin
-113.06%
Oper. margin
-98.39%
Gross margin
64.26%
EBIT margin
-98.39%
EBITDA margin
-68.73%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

TELA Bio stock price history

TELA Bio stock forecast

TELA Bio financial statements

TELA Bio, Inc. (NASDAQ:TELA): Profit margin
Jun 2023 14.49M -10.79M -74.44%
Sep 2023 15.05M -10.95M -72.79%
Dec 2023 16.99M -12.89M -75.83%
Mar 2024 16.60M -5.66M -34.1%
TELA Bio, Inc. (NASDAQ:TELA): Analyst Estimates
Sep 2025 25.24M -6.27M -24.88%
Oct 2025 24.8M -5.89M -23.79%
Dec 2025 27.65M -5.57M -20.16%
Dec 2025 27.46M -5.16M -18.79%
  • Analysts Price target

  • Financials & Ratios estimates

TELA Bio, Inc. (NASDAQ:TELA): Debt to assets
Jun 2023 94386000 54.38M 57.62%
Sep 2023 87317000 56.76M 65.01%
Dec 2023 78048000 59.16M 75.81%
Mar 2024 71837000 57.45M 79.98%
TELA Bio, Inc. (NASDAQ:TELA): Cash Flow
Jun 2023 -11.26M -157K 46.40M
Sep 2023 -6.96M -134K 71K
Dec 2023 -11.05M -193K 22K
Mar 2024 -14.38M 4.69M 56K

TELA Bio alternative data

TELA Bio, Inc. (NASDAQ:TELA): Employee count
Aug 2023 173
Sep 2023 173
Oct 2023 173
Nov 2023 173
Dec 2023 173
Jan 2024 173
Feb 2024 173
Mar 2024 227
Apr 2024 227
May 2024 227
Jun 2024 227
Jul 2024 227

TELA Bio other data

100.00% 0.00%
of TELA is owned by hedge funds
17.31M +528.70K
shares is hold by hedge funds

TELA Bio, Inc. (NASDAQ:TELA): Insider trades (number of shares)
Period Buy Sel
Nov 2023 21000 0
Dec 2023 2600 0
Jun 2024 0 378000
Jul 2024 0 50300
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ORBIMED ADVISORS LLC 10 percent owner
Common Stock 36,600 $4.54 $166,164
Sale
ORBIMED ADVISORS LLC 10 percent owner
Common Stock 13,700 $4.68 $64,116
Sale
ORBIMED ADVISORS LLC 10 percent owner
Common Stock 378,000 $4.74 $1,791,720
Purchase
FIRESTONE GREGORY A. officer: Chief Business Officer
Common Stock 2,600 $5.65 $14,687
Purchase
CUCA ROBERTO officer: COO and CFO
Common Stock 10,000 $4.49 $44,940
Purchase
KOBLISH ANTONY director, officer.. Common Stock 11,000 $4.54 $49,973
Sale
ORBIMED ADVISORS LLC 10 percent owner
Common Stock 27,700 $9.41 $260,657
Sale
ORBIMED ADVISORS LLC 10 percent owner
Common Stock 28,300 $9.43 $266,869
Sale
ORBIMED ADVISORS LLC 10 percent owner
Common Stock 136,000 $9.3 $1,264,800
Option
BURGESS VINCENT J director Common Stock 4,860 $4.44 $21,578
Patent
Application
Filling date: 18 May 2022 Issue date: 1 Sep 2022
Grant
Filling date: 28 Aug 2019 Issue date: 28 Jun 2022
Grant
Filling date: 25 Feb 2019 Issue date: 31 May 2022
Application
Filling date: 8 Mar 2019 Issue date: 24 Dec 2020
Application
Filling date: 6 Jul 2020 Issue date: 22 Oct 2020
Application
Filling date: 4 Jun 2020 Issue date: 24 Sep 2020
Application
Filling date: 9 Mar 2020 Issue date: 10 Sep 2020
Application
Filling date: 14 Feb 2020 Issue date: 13 Aug 2020
Grant
Filling date: 19 Jul 2016 Issue date: 7 Jul 2020
Grant
Filling date: 15 Nov 2017 Issue date: 18 Feb 2020
Insider Compensation
Mr. Antony Koblish (1966) Co-founder, Pres, Chief Executive Officer & Director $806,250
Dr. E. Skott Greenhalgh Ph.D. (1968) Chief Technology Officer
$488,630
Friday, 13 December 2024
globenewswire.com
Tuesday, 19 November 2024
globenewswire.com
Saturday, 9 November 2024
seekingalpha.com
Thursday, 7 November 2024
zacks.com
Friday, 1 November 2024
globenewswire.com
Thursday, 24 October 2024
globenewswire.com
Wednesday, 23 October 2024
globenewswire.com
Tuesday, 22 October 2024
globenewswire.com
Thursday, 17 October 2024
globenewswire.com
Monday, 12 August 2024
seekingalpha.com
zacks.com
globenewswire.com
Friday, 9 August 2024
globenewswire.com
Monday, 22 July 2024
globenewswire.com
Tuesday, 4 June 2024
globenewswire.com
Monday, 20 May 2024
globenewswire.com
Saturday, 11 May 2024
Seeking Alpha
Thursday, 21 March 2024
Seeking Alpha
Zacks Investment Research
Thursday, 29 February 2024
GlobeNewsWire
Tuesday, 16 January 2024
Seeking Alpha
Sunday, 12 November 2023
Seeking Alpha
Thursday, 26 October 2023
GlobeNewsWire
Wednesday, 9 August 2023
Zacks Investment Research
Wednesday, 26 July 2023
GlobeNewsWire
Monday, 19 June 2023
Zacks Investment Research
Thursday, 25 May 2023
GlobeNewsWire
Sunday, 14 May 2023
Seeking Alpha
Thursday, 11 May 2023
Zacks Investment Research
Thursday, 27 April 2023
GlobeNewsWire
  • What's the price of TELA Bio stock today?

    One share of TELA Bio stock can currently be purchased for approximately $1.76.

  • When is TELA Bio's next earnings date?

    Unfortunately, TELA Bio's (TELA) next earnings date is currently unknown.

  • Does TELA Bio pay dividends?

    No, TELA Bio does not pay dividends.

  • How much money does TELA Bio make?

    TELA Bio has a market capitalization of 111.95M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 41.13% to 58.45M US dollars.

  • What is TELA Bio's stock symbol?

    TELA Bio, Inc. is traded on the NASDAQ under the ticker symbol "TELA".

  • What is TELA Bio's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of TELA Bio?

    Shares of TELA Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are TELA Bio's key executives?

    TELA Bio's management team includes the following people:

    • Mr. Antony Koblish Co-founder, Pres, Chief Executive Officer & Director(age: 59, pay: $806,250)
    • Dr. E. Skott Greenhalgh Ph.D. Chief Technology Officer(age: 57, pay: $488,630)
  • Is TELA Bio founder-led company?

    Yes, TELA Bio is a company led by its founder Mr. Antony Koblish.

  • How many employees does TELA Bio have?

    As Jul 2024, TELA Bio employs 227 workers.

  • When TELA Bio went public?

    TELA Bio, Inc. is publicly traded company for more then 5 years since IPO on 8 Nov 2019.

  • What is TELA Bio's official website?

    The official website for TELA Bio is telabio.com.

  • Where are TELA Bio's headquarters?

    TELA Bio is headquartered at 1 Great Valley Parkway, Malvern, PA.

  • How can i contact TELA Bio?

    TELA Bio's mailing address is 1 Great Valley Parkway, Malvern, PA and company can be reached via phone at +48 43202930.

TELA Bio company profile:

TELA Bio, Inc.

telabio.com
Exchange:

NASDAQ

Full time employees:

227

Industry:

Medical - Devices

Sector:

Healthcare

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

1 Great Valley Parkway
Malvern, PA 19355

CIK: 0001561921
ISIN: US8723811084
CUSIP: 872381108